Article
Single-cell genomic approaches for developing the next generation of immunotherapies.
Nature medicine - 1 Feb 2020
Yofe Ido, Dahan Rony, Amit Ido
Abstract excerpt
Recent progress in single-cell genomics urges its application in drug development, particularly of cancer immunotherapies. Current immunotherapy pipelines are focused on functional outcome and simple cellular and molecular readouts. A thorough mechanistic understanding of the cells and pathways targeted by immunotherapy agents is lacking, which limits the success rate of clinical trials. A large leap forward can...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
